Council of the European Union decisions on designer drugs

Today we want to talk about Council of the European Union decisions on designer drugs, a topic that has captured the attention of many in recent times. Council of the European Union decisions on designer drugs is a topic that covers a wide range of aspects and may be of interest to a very diverse audience. From its impact on current society to its historical relevance, Council of the European Union decisions on designer drugs can be analyzed from different perspectives and find its place in various fields of knowledge. In this article we will explore some of the most relevant facets of Council of the European Union decisions on designer drugs, to understand its importance and the implications it has today.

Council of the European Union decisions on designer drugs. Council of the European Union issued a set of decisions on 7 designer drugs to make them subject to control measures and criminal provisions.

List of substances

Decisions

Decisions based on Joint Action 97/396/JHA of 16 June 1997 adopted by the Council on the basis of Article K.3 of the Treaty on European Union, concerning the information exchange, risk assessment and the control of new synthetic drugs:

Decisions based on Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances:

Sources

See also

External links